TCF4 and nasopharyngeal carcinoma: For instance, miR-506 can prevent the metastasis and progression of NPC by downregulating LHX2, decreasing TCF4, and inhibiting Wnt/β-catenin signaling pathway [14]; miR-203a-3p targets LASP1 to prevent NPC development and metastasis [15].